Sonovascular
Chapel Hill, US · Founded 2018 · 2 known investors
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
BiotechHealthtechMedical Devices
Founders & leadership
WN
William N. StarlingDirector
DE
Daniel EstayExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$2.2MraisedJan 2023 · 26 investors · Other Health CareRule 506(b)
▶$2.2MraisedJan 2023 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William N. StarlingDirector
- Daniel EstayExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Dec 2021
- Incorporated
- Corporation, North Carolina, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.